India, Feb. 4 -- Shares of Quantum BioPharma Ltd. (QNTM) jumped over 66% on Tuesday morning after the biopharmaceutical company announced positive data of its dietary supplement product unbuzzd in a clinical trial.
QNTM is currently trading at $5.34, up $2.16 or 66.26%, on the Nasdaq. The stock opened its trading at $5.76 after closing Monday at $3.18. The stock has traded between $2.70 and $70.85 in the past 52-week period.
Quantum BioPharma announced that it has completed a double-blind, randomized, placebo-controlled crossover design clinical trial (NCT06505239) of its dietary supplement product unbuzzd, investigating its effects on alcohol intoxication and alcohol metabolism.
The company said the trial confirmed that unbuzzd dramatic...